

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mg | 180 pill | β¬2.53 | β¬606.78 β¬455.08 Best Price Popular | |
| 100mg | 120 pill | β¬2.59 | β¬413.36 β¬310.02 | |
| 100mg | 90 pill | β¬2.76 | β¬331.82 β¬248.87 | |
| 100mg | 60 pill | β¬3.10 | β¬248.39 β¬186.29 | |
| 100mg | 30 pill | β¬4.12 | β¬164.95 β¬123.72 |
Disclaimer: This information is for general reference and should not replace medical advice. Always follow your doctorβs instructions and the patient information leaflet that accompanies your medicine.
Epivir HBV is a brand name for lamivudine, an antiviral medicine used to treat chronic hepatitis B infection. It works to slow the growth of the hepatitis B virus in the liver. By reducing the amount of virus, it can help lower liver inflammation and the risk of liver damage when used under medical supervision.
In Ireland, Epivir HBV may require a prescription depending on local rules. You should obtain it through a pharmacist with a valid prescription or under the supervision of a clinician. Do not take Epivir HBV that was prescribed for someone else or that is past its expiry date.
Lamivudine belongs to a class of antiviral medicines called nucleoside analogues. It interferes with the virusβs ability to copy its genetic material, which helps to control the infection in the liver. The medicine is prescribed as part of a comprehensive treatment plan tailored to the individual patient.
Your healthcare team will explain why Epivir HBV has been chosen for you, how it fits with other treatments you may be taking, and what to expect during therapy. Always read the official patient information leaflet provided with the medicine for full details and safety information.
Epivir HBV is primarily used to treat chronic hepatitis B virus infection. It is designed for adults and for certain children under medical supervision as part of a broader treatment plan. The aim is to reduce the amount of virus in the blood and liver, helping to decrease liver inflammation and slow disease progression.
In some cases, Epivir HBV is used in people who also have HIV infection as part of a combination therapy. The exact use depends on individual health status and local clinical guidelines. Your doctor will determine whether this medicine is appropriate for you and will adjust the plan if needed.
Epivir HBV does not guarantee a cure. It can lower viral activity and support liver health, but ongoing monitoring is essential. Regular blood tests and liver function tests are commonly performed to assess response and safety during treatment.
As with all medicines that treat chronic infections, the use of Epivir HBV is guided by professional medical advice. If you have questions about whether this medicine is right for you, discuss them with your doctor or pharmacist and refer to the official leaflet for the product you receive.
Lamivudine acts as a building block that the hepatitis B virus uses to copy its genetic material. By substituting a faulty building block, it interrupts the production of new viral DNA. This reduces the amount of virus replicating in the liver and helps the immune system control the infection.
The antiviral effect depends on taking the medicine as prescribed. Missing doses or stopping treatment without medical advice can allow the virus to rebound and may contribute to resistance over time. Your clinician will monitor your response with tests to track the level of virus and liver function.
Epivir HBV does not immediately eliminate the virus in every person. The overall aim is to achieve sustained suppression of viral activity and improvement in liver-related health outcomes where possible. The treatment plan, including duration, is individualized based on clinical factors.
Interactions with other medicines can influence how well lamivudine works. It is important to tell your healthcare team about all medicines you take, including over-the-counter drugs and herbal products. Always consult before starting or stopping any other treatment.
Take Epivir HBV exactly as prescribed by your doctor. The medicine is usually taken by mouth and swallowed with a drink of water. It may be taken with or without food, depending on your doctorβs instructions. Do not chew or crush the tablets unless the packaging or leaflet says it is allowed.
Try to take Epivir HBV at the same time every day. If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one unless advised by your doctor or pharmacist.
The length of treatment is determined by your clinician. Do not stop taking Epivir HBV without talking to your healthcare professional, even if you feel well. Stopping too soon or without guidance can affect how well the infection is controlled.
Storage and disposal: Keep the medication in its original container, away from moisture, heat, and direct light. Store at room temperature and out of reach of children. Do not use Epivir HBV after the expiry date. If you have unused tablets, ask your pharmacist how to dispose of them safely.
Special situations: If you have kidney disease or are taking other medicines that affect the kidneys, your dose or regimen may be adjusted. If you are pregnant or breastfeeding, discuss with your clinician before starting Epivir HBV. Do not share this medicine with others.
Do not take Epivir HBV if you know you are allergic to lamivudine or any of the ingredients in the medicine. Symptoms of an allergic reaction can include rash, itching, swelling of the face or throat, or trouble breathing. Seek medical help promptly if you notice any signs of an allergic reaction.
Tell your doctor if you have severe kidney impairment or a history of lactic acidosis or serious liver problems. In these cases, the doctor will carefully weigh the benefits and risks and may adjust the treatment or choose an alternative therapy.
Pregnancy and breastfeeding: Discuss with your doctor if you are pregnant or planning to become pregnant or if you are breastfeeding. The doctor will weigh the potential benefits and risks for both mother and baby and may adjust the treatment plan accordingly.
Epivir HBV contains ingredients that may not be suitable for people with certain medical conditions or those taking specific medicines. Always check with your pharmacist or doctor if you are unsure about interactions with other medicines you are taking.
Lamivudine can, in rare cases, be associated with lactic acidosis and severe liver problems. Seek urgent medical help if you develop persistent nausea, vomiting, abdominal pain with breathing difficulties, or unusual sleepiness or confusion.
Inform your doctor about all medicines you take, including non-prescription drugs and herbal products. Some medicines can interact with lamivudine and influence how Epivir HBV works or increase the risk of side effects.
People with a history of liver disease, kidney impairment, or those who have had a liver transplant may require additional monitoring during treatment. Regular laboratory tests are commonly performed to check how well the treatment is working and to detect any safety issues early.
Do not share this medicine with others. Use only the medicine prescribed for you and follow the plan given by your healthcare professional to reduce the risk of resistance or ineffective treatment.
All medicines can cause side effects in some people. Most people taking Epivir HBV tolerate it well, but some may experience adverse effects.
Common side effects may include headache, dizziness, tiredness, nausea, diarrhoea, or stomach upset. These are usually mild and may improve with time or after minor adjustments to how you take the medicine.
Less common side effects can include rash, itching, or hives. In very rare cases, swelling, mouth ulcers, or trouble breathing may occur and require medical attention.
Serious effects such as signs of lactic acidosis or liver problems should be reported to a doctor immediately. If you notice persistent fatigue, rapid breathing, severe stomach pain with vomiting, or yellowing of the skin or eyes, seek urgent medical help.
Tell your doctor or pharmacist about all medicines you are taking, including prescription drugs, over-the-counter medicines, and herbal or complementary products. Some medicines can interact with lamivudine and affect how well Epivir HBV works or increase side effects.
Possible interactions include other antiviral medicines used for HIV or hepatitis B. Your clinician may adjust your treatment plan if such medicines are being taken together.
Vaccines and immune therapies: Some vaccines or immune-based treatments could interact with antiviral therapy or affect the immune response. If you receive vaccines during treatment, inform your healthcare team about all medicines you are taking.
Kidney disease or dialysis: In people with kidney problems, the doctor may adjust the dose to prevent drug accumulation. Do not change your dose without professional advice.
If you are pregnant or planning pregnancy, discuss Epivir HBV with your doctor. They will weigh the potential risks and benefits for you and the baby. In certain circumstances antiviral treatment may be continued during pregnancy to protect the health of the mother and baby, but the decision depends on your health status and disease activity.
Lamivudine can pass into breast milk. If you are breastfeeding or planning to breastfeed, talk to your doctor about whether Epivir HBV is appropriate for you. The doctor may suggest alternatives if needed to protect the baby.
Do not stop treatment abruptly during pregnancy without medical advice. It is important to follow the prescribed plan and attend regular check-ups during pregnancy while on antiviral therapy.
These frequently asked questions provide general guidance about Epivir HBV in Ireland. They are not a substitute for personalised medical advice. Always consult your clinician for individual guidance and refer to the official leaflet that accompanies the medicine.
Response times can vary among individuals. Some people see improvements in liver function tests over weeks to months, while changes in viral load may take longer. Your healthcare team will monitor progress with regular blood tests.
If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to compensate for a missed one unless advised by a healthcare professional.
Combining Epivir HBV with other antiviral treatments is common in some treatment plans. Do not change therapy without medical advice and ensure you are monitored for interactions and efficacy.
Contact a healthcare professional if you experience signs of an allergic reaction, severe side effects, or a sudden change in your condition. Seek urgent medical help for symptoms such as severe abdominal pain, yellowing of the skin, or trouble breathing.
Results can vary between individuals. Some people may notice improvements in liver function tests over several weeks, while others may require longer treatment. Ongoing monitoring by your clinician is essential to assess response and safety.
Take the missed dose as soon as you remember, unless it is almost time for the next scheduled dose. Do not double up to make up for a missed dose. If you are unsure what to do, contact your pharmacist or doctor for guidance.
In some cases Epivir HBV may be used as part of a combination therapy. Any changes to therapy should only be made under the supervision of a clinician. Be sure to inform your healthcare team about all medicines you take to manage potential interactions.
Report any persistent or severe side effects to your doctor or pharmacist. They can assess whether the symptoms are related to Epivir HBV and decide whether a dose adjustment or alternative treatment is needed.
Safety in pregnancy depends on individual health factors and the potential benefits to both mother and baby. Discuss with your doctor to weigh risks and benefits before starting or continuing therapy during pregnancy.
Moderate to heavy alcohol use can worsen liver disease. It is best to discuss alcohol use with your doctor, who can advise based on your liver health and overall treatment plan.
Vaccines and antiviral therapies can interact in some cases. Inform your healthcare team about all medicines you are taking, including vaccines, to ensure proper timing and avoid reduced effectiveness or adverse effects.
Your clinician may order blood tests to measure liver function and viral load, kidney function, and other safety checks. Tests help guide treatment decisions and ensure the regimen remains appropriate for your health status.
Do not stop Epivir HBV or change therapy without consulting your doctor. Abrupt changes can affect how well the infection is controlled and may lead to resistance or disease flare-ups.
Yes. Inform your pharmacist about all prescribed medicines, over-the-counter drugs, vitamins, and herbal products. This helps identify potential interactions and ensures safer handling of your treatment plan.
The information provided here is based on general product information and typical clinical practice for lamivudine-containing therapies used to treat chronic hepatitis B. For the most accurate and up-to-date details, consult the official patient information leaflet that accompanies Epivir HBV, or speak with a pharmacist or healthcare professional in Ireland.
Your doctor or pharmacist can explain how Epivir HBV applies to your specific condition, including any local requirements for prescription status and monitoring plans. Regular follow-up appointments and laboratory testing are important parts of safe and effective treatment.
For additional reading, patients are encouraged to review the leaflet supplied with their medication and to ask questions if any information is unclear. The leaflet provides full details on indications, contraindications, precautions, and safety information relevant to Epivir HBV.
14β21 days. Free from β¬171.35 .
5β9 days. β¬25.70
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.